Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment

被引:77
作者
Bergmann, Christoph
Strauss, Laura
Zeidler, Reinhard
Lang, Stephan
Whiteside, Theresa L.
机构
[1] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA
[2] Univ Munich, Dept Otorhinolaryngol, D-81377 Munich, Germany
[3] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45127 Essen, Germany
关键词
Tr1; cells; T-reg; HNSCC; immune suppression; tumor escape; rapamycin;
D O I
10.1007/s00262-007-0280-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Chronic inflammation and cancer development are associated with dysregulated immune responses and the presence of regulatory T cells (T-reg). To study the role of T-reg in tumor cell escape from immune surveillance, an in vitro model simulating the tumor microenvironment and promoting the induction and expansion of IL-10(+) T-reg type 1 (Tr1) was established. Methods An in vitro co-culture system (IVA) included an irradiated head and neck squamous cell carcinoma cell line, immature dendritic cells (iDC), CD4(+)CD25(-)T cells and cytokines, IL-2 (10 IU/ml), IL-10 (20 IU/ml), IL-15 (20 IU/ml) +/- 1 nM rapamycin. Autologous iDC and CD4(+)CD25(-) T cells were obtained from the peripheral blood of 15 normal donors. Co-cultures were expanded for 10 days. Proliferating lymphocytes were phenotyped by multi-color flow cytometry. Their suppressor function was measured in CFSE inhibition assays +/- neutralizing anti-IL-10 mAb and using transwell cultures. Culture supernatants were tested for IL-4, IL-10, TGF-beta and IFN-gamma in ELISA. Results In the IVA, low doses of IL-2, IL-10 and IL-15 promoted induction and expansion of CD3(+)CD4(+)CD25(-)IL2R beta(+)IL2R gamma(+)FoxP3(+)CTLA-4(+)IL-10(+) cells with suppressor activity (mean suppression +/- SD = 58 +/- 12%). These suppressor cells produced IL-10 (mean +/- SD = 535 +/- 12 pg/ml) and TGF-beta (mean +/- SD = 512 +/- 38 pg/ml), but no IL-4 or IFN-gamma. Suppressor function of co-cultures correlated with the percent of expanding IL-10(+) Tr1 cells (r(2) =0.9; P < 0.001). The addition of rapamycin enriched Tr1 cells in all co-cultures. Neutralizing anti-IL-10 mAb abolished suppressive activity. Suppression was cell-contact independent. Conclusion The tumor microenvironment promotes generation of Tr1 cells which have the phenotype distinct from that of CD4(+)CD25(high)FoxP3(+) nTreg and mediate IL-10 dependent immune suppression in a cell-contact independent manner. Tr1 cells may play a critical role in cancer progression.
引用
收藏
页码:1429 / 1442
页数:14
相关论文
共 42 条
  • [1] Immunopharmacology of rapamycin
    Abraham, RT
    Wiederrecht, GJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 483 - 510
  • [2] Assenmacher M, 1998, J IMMUNOL, V161, P2825
  • [3] HIGH-LEVELS OF INTERLEUKIN-10 PRODUCTION IN-VIVO ARE ASSOCIATED WITH TOLERANCE IN SCID PATIENTS TRANSPLANTED WITH HLA MISMATCHED HEMATOPOIETIC STEM-CELLS
    BACCHETTA, R
    BIGLER, M
    TOURAINE, JL
    PARKMAN, R
    TOVO, PA
    ABRAMS, J
    MALEFYT, RD
    DEVRIES, JE
    RONCAROLO, MG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 493 - 502
  • [4] Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO
  • [5] 2-2
  • [6] Regulatory cells and human cancer
    Baecher-Allan, C
    Anderson, DE
    [J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (02) : 98 - 105
  • [7] Suppressor T cells in human diseases
    Baecher-Allan, C
    Hafler, DA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) : 273 - 276
  • [8] Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation
    Barchet, W
    Price, JD
    Cella, M
    Colonna, M
    MacMillan, SK
    Cobb, JP
    Thompson, PA
    Murphy, KM
    Atkinson, JP
    Kemper, C
    [J]. BLOOD, 2006, 107 (04) : 1497 - 1504
  • [9] In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines
    Barrat, FJ
    Cua, DJ
    Boonstra, A
    Richards, DF
    Crain, C
    Savelkoul, HF
    de Waal-Malefyt, R
    Coffman, RL
    Hawrylowicz, CM
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : 603 - 616
  • [10] Tr1 cells: From discovery to their clinical application
    Battaglia, M
    Gregori, S
    Bacchetta, R
    Roncarolo, MG
    [J]. SEMINARS IN IMMUNOLOGY, 2006, 18 (02) : 120 - 127